Please contact us for more information or to learn if you are eligible to participate.
The purpose of the TESLA study is establish the effectiveness of intra-arterial treatment (IAT). Patients presenting with symptoms of arterial ischemic stroke who have evidence of a moderate-large infarct volume [NCCT ASPECTS 2-5] in the anterior circulation will be assigned to either best medical management alone (including IV rtPA) or intra-arterial treatment (IAT) with mechanical thrombectomy added to best medical management. Each treated patient will be followed and assessed for 3 months after randomization.
Patricia Fernandez, M.D.
Mercy Health Ohio
Type of Trial